References

  1. Globocan. Estimated cancer incidence, mortality and prevalence worldwide. 2012. Consulté le 25 Décembre 2016.

  2. Espié M. The management of breast cancer. Diagnostic and Interventional Imaging. July-August 2014; 95(7-8): 753-757. Epub 2014 May 22. PubMed | Google Scholar

  3. Belkacémi Y, Boussen H, Hamdi-Cherif M et al. Epidemiology of breast cancer in young women in North Africa. 32nd Meeting of the French Society of Senology and Breast Pathology. Journées, Strasbourg, FRA. Novembre 2010; 56-68.

  4. Traore B, Barry Sonna M, Dassy E et al. Over Review of Three Years (2007-2009) Activities of the Unit of Surgical Oncology, National Hospital of Donka. Guinée Médicale. 2011; 72: 11-18.

  5. Traoré B, Keita M, Diane S, Dankoro A, Kabba IS, Keita N. Clinicopathological study of breast diseases presenting to the surgical oncology unit of Donka University Hospital in Conakry, Guinea. West Afr J Med. 2012; 31(4): 227-31. PubMed | Google Scholar

  6. Elima JA, Adébamowo C, Isabel DSS. Stage at diagnosis of breast cancer in sub-saharan Africa: a systematic review and méta analysis. Lancet Glob Health. 2016; 4(12): e923-e935. PubMed | Google Scholar

  7. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumors. Nature. 2000 Aug 17; 406(6797): 747-52. PubMed | Google Scholar

  8. Boisserie-Lacroixa M, Bullier B, Hurtevent-Labrota G, Ferron S, Lippa N, Mac Grogan G. Corrélation between imaging and prognostic factors: molecular classification of breast cancers. Journal of Diagnostic and Interventional Imaging. 2014; 95(2): 227-233. PubMed | Google Scholar

  9. Traore B, Toure A, Sy T, Mamadou Moustapha Dieng, Mamoudou Condé, Ahmadou Deme et al. Prognosis of Breast Cancer Patients Underwent Surgery in a Developing Country. Journal of Cancer Therapy. September 2015; 6(9): 803-810. Google Scholar

  10. Nfawor CC, Keshinro SO. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-saharan breast cancer cases: Private practice experience. Niger J Clin Pract. 2015; 18(4): 553-8. PubMed | Google Scholar

  11. Ohene-Yeboah M, Adjei E. Breast cancer in Kumasi. Ghana Ghana Med J. 2012; 46(1): 8-13. PubMed | Google Scholar

  12. Ahoua BE, Nguiessan AA, Baumaney SK et al. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast. BMC Cancer. 2017; 17(1): 115. PubMed | Google Scholar

  13. Venderpuye V, Grover S, Hammad N, PoojaPrabhakar, Simonds H, Olopade F et al. An update on the management of breast cancer in Africa. Infect Agent Cancer. 2017; 12: 13. PubMed | Google Scholar

  14. Cherbal F, Gaceb H, Mehemmai C, Saiah I, Bakour R, Rouis AO et al. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristic: a population-based study. Breast Dis. 2015; 35(2): 95-102. PubMed | Google Scholar

  15. Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10159 cases from 12 studies. Plos Med. 2010; 7(5):e1000279. PubMed | Google Scholar

  16. Fregene A, Newman LA. Breast cancer in sub-saharan Africa: how does it relate to breast cancer in African-American women? Cancer. 2005; 103(8): 1540-50. PubMed | Google Scholar

  17. The Northern Ireland Cancer Registry. Northern Ireland annual cancer incidence and survival statistics. May 2016. Consulté le 10 Oct 20.

  18. Gakwaya A, Kigula-Mugambe JB, Kavuma A, Luwaga A, Fualal J, Jombwe J et al. Cancer of the breast: 5years survival in a tertiary hospital in Uganda. Br J Cancer. 2008; 99(1):63-67. PubMed | Google Scholar

  19. Guinée. Enquête démographique et de santé et à indicateurs multiples (EDS-MICS). Santé reproductive dans l'EDS-MICS. 2012. consulted on December 30th, 2017.

  20. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295(21): 2492-502. PubMed | Google Scholar

  21. Blamey RW, Hornmark-Stenstam B, Ball G, Blichert-Toft M, Cataliotti L, Fourquet A et al. ONCOPOOL-European database for 16 944 cases of breast cancer. Eur J Cancer. 2010; 46(1): 56-71. PubMed | Google Scholar

  22. Jedy-Agba E, McCormack V, Olaomi O, Badejo W, Yilkudi M, Yawe T et al. Determinants of stage at diagnosis of breast cancer in Nigerian women: Sociodemographic, Breast cancer Awareness, Health Care access and clinical factors. Cancer Causes Control. 2017 Jul; 28(7): 685-697. Epub 2017 Apr 26. PubMed | Google Scholar

  23. McCormack VA, Joffe M, van den Berg E, Broeze N, Silva Idos S, Romieu I et al. Breast cancer receptor status and stage at diagnosis in over 1200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res. 2013; 15(5): R84. PubMed | Google Scholar

  24. Lumachi F, Brunello A, Maruzzo M, Basso U, Basso SM. Treatment of estrogen receptor-positive breast cancer. Curr Med Chem. 2013; 20(5): 596-604. PubMed | Google Scholar

  25. Lisa KD, Mary AR, Christopher IL. Hormone receptor status, tumor characteristics and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9(1): R6. PubMed | Google Scholar

  26. Ly M, Antoine M, Dembélé AK, Levy P, Rodenas A, Touré BA et al. High incidence of triple-negative tumors in sub-Saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Oncology. 2012; 83(5): 257-63. Epub 2012 Sep 4. PubMed | Google Scholar

  27. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol. 2009; 27(27): 4515-4521. Epub 2009 Aug 24. PubMed

  28. Seshie B, Adu-Aryee NA, Dedey F, Calys-Tagoe B, Clegg-Lamptey JN. A retrospective analysis of breast cancer subtype based on ER / PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana. BMC Clin Pathol. 2015; 15: 14. PubMed | Google Scholar

  29. Zell JA, Tsang WY, Taylor TH, Mehta RS, Anton-Culver H. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2014 IBC patient cases from the California cancer registry. Breast Cancer Res. 2009; 11(1): R9. Epub 2009 Feb 19. PubMed | Google Scholar

  30. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat. 2008; 110(1): 183-88. Epub 2007 Aug 3. PubMed | Google Scholar